Clinical Trial Update: To Study Generic Calcipotriene and Betamethasone Dipropionate Topical Foam, 0.005%/0.064%, in the Treatment of Psoriasis Vulgaris (Plaque Psoriasis). [Phase 3]

View source ↗

Summary

Phase 3 trial studying generic calcipotriene and betamethasone dipropionate topical foam for psoriasis vulgaris has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis Vulgaris

Drugs mentioned

• Calcipotriene and betamethosone dipropionate topical foam, 0.005%/0.064% (calcipotriene and betamethasone dipropionate topical foam)

Snippet

Sponsor: Glenmark Pharmaceuticals Ltd. India | Conditions: Psoriasis Vulgaris | Phase 3 | Status: COMPLETED